title: Session V: The neonatal immune system: window of opportunity?
authors.forename: L
authors.initials: L
authors.lastname: Bailey
authors.forename: B
authors.initials: B
authors.lastname: Kahan
authors.forename: S
authors.initials: S
authors.lastname: Nehlsen-Cannarella
authors.forename: J
authors.initials: J
authors.lastname: Sprent
authors.forename: V
authors.initials: V
authors.lastname: Starnes
authors.forename: M
authors.initials: M
authors.lastname: Yacoub
mesh_terms: D015415:Biomarkers; D002985:Clinical Protocols / Q000592:standards; D003524:Cyclosporins / Q000009:adverse effects / Q000627:therapeutic use; D016027:Heart Transplantation / Q000276:immunology* / Q000592:standards; D006801:Humans; D007108:Immune Tolerance; D007165:Immunosuppression Therapy / Q000009:adverse effects / Q000379:methods; D007231:Infant, Newborn / Q000276:immunology*; D014181:Transplantation Immunology
chemical_list: D015415:Biomarkers; D003524:Cyclosporins